Search alternatives:
altered decrease » altered release (Expand Search), observed decrease (Expand Search), teer decrease (Expand Search)
altered decrease » altered release (Expand Search), observed decrease (Expand Search), teer decrease (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Viloxazine Extended-Release: A Review of in Attention-Deficit/Hyperactivity Disorder in Adults
Published 2025“…</p><p><br></p><p dir="ltr"><b>Ethics approval, Consent to participate, Consent to publish, Availability of data and material, Code availability</b> not applicable</p><p><br></p><p dir="ltr">Additional information about this Adis Drug Review can be found <a href="https://www.springer.com/gp/adis/products-services/adis-journals-newsletters/adis-drug-reviews" target="_blank">here</a></p><p><br></p><p dir="ltr"><b>Abstract</b></p><p dir="ltr">An extended-release once-daily oral capsule formulation of viloxazine (viloxazine ER; Qelbree®), a norepinephrine reuptake inhibitor and serotonin receptor modulator, has been approved in the USA for the treatment of attention-deficit/hyperactivity disorder (ADHD) in paediatric patients and adults. …”
-
8
-
9
-
10
Sodium oxybate extended-release suspension (LUMRYZ™) in narcolepsy: a profile of its use
Published 2024“…</p> <p><br></p> <p> </p> <p><strong>Abstract </strong>Sodium oxybate extended-release suspension (LUMRYZ™; hereafter referred to as sodium oxybate ER) represents a promising novel option for the treatment of narcolepsy. …”
-
11
-
12
-
13
-
14
Effect of previous administration of extended-release buprenorphine (1 mg/kg SC) or saline in rats using a warm-water tail flick assay to assess acute thermal nociception.
Published 2024“…A) Efficacy in response to standard buprenorphine at 1 mg/kg and 3 mg/kg was significantly decreased in rats previously exposed to extended-release buprenorphine (Bupe ER) vs. those exposed to saline. …”
-
15
-
16
-
17
-
18
-
19
-
20